inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester has been researched along with Alzheimer Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
LaFerla, FM; Leissring, MA; Parker, I | 1 |
1 other study(ies) available for inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester and Alzheimer Disease
Article | Year |
---|---|
Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4,5-trisphosphate-mediated calcium signals.
Topics: Alzheimer Disease; Animals; Calcium Channels; Calcium Signaling; Gene Expression; Humans; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Kinetics; Membrane Proteins; Microinjections; Mutation; Oocytes; Photolysis; Presenilin-2; Receptors, Cytoplasmic and Nuclear; RNA, Complementary; Ultraviolet Rays; Xenopus | 1999 |